1. Growth retardation and cell death in mouse embryos following exposure to the teratogen bromodeoxyuridine
- Author
-
David S. Packard, Robert A. Menzies, and Richard G. Skalko
- Subjects
Programmed cell death ,animal structures ,Cell division ,Cell Survival ,Placenta ,Clinical Biochemistry ,Spleen ,Biology ,Tritium ,Pathology and Forensic Medicine ,Andrology ,Mice ,chemistry.chemical_compound ,Pregnancy ,medicine ,Animals ,Molecular Biology ,Mice, Inbred ICR ,Embryo ,DNA ,Organ Size ,Embryo, Mammalian ,Teratology ,Teratogens ,medicine.anatomical_structure ,Bromodeoxyuridine ,chemistry ,embryonic structures ,Immunology ,Female ,Thymidine ,Cell Division - Abstract
Within 24 hr after injection of mice on day 10 of pregnancy, embryos exposed to a teratogenic dose of 3H-bromodeoxyuridine (3H-BrdU) have smaller wet weights than control embryos exposed to a trace dose of 3H-thymidine (3H-TdR) or a trace dose of 3H-BrdU. This difference increased by 48 hr after injection. Measurements of total embryo DNA content indicate that these lighter embryos contain fewer cells than controls. If cell death plays a role in the observed growth retardation following administration of 3H-BrdU, one would expect label to be lost from the embryo DNA fraction. Following injection of a trace dose of 3H-TdR or 3H-BrdU, total embryo DNA label rapidly reached peak levels and remained at those levels for at least 48 hr after injection. However, within 48 hr of administering a teratogenic dose of 3H-BrdU, total embryo DNA label had decreased to 25% of peak levels. Histological evidence of cell death was found in the embryos, although it is not yet clear whether cell death was sufficiently extensive to account for the amount of label lost from the DNA fraction. Since none of these BrdU-induced cytotoxic effects were found in the maternal liver, spleen, kidney, or placenta, it is concluded that BrdU probably exerts its teratogenic effects directly on the embryo.
- Published
- 1974